The relationship between neuropathic pain and lower urinary tract symptom scores in patients with primary Sjögren’s syndrome

• Published in: BMC urology Vol. 24; no. 1; p. 257
• Main Authors: Erdik, Nilay, Erdik, Anil, Kizil, Damla, Yavuzbilge, Gokhan, Turk, Sumeyye Merve, Guneysu, Cansu Arslanturk, Karakurt, Abbas, Ozmen, Sedat, Gonullu, Emel
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 20-11-2024; BioMed Central
• Subjects: Care and treatment; Health aspects; Medical research; Medicine, Experimental; Urinary incontinence
• ISSN: 1471-2490; 1471-2490
• DOI: 10.1186/s12894-024-01650-1

To evaluate the effect of neuropathic pain on lower urinary tract symptoms (LUTS) scores in patients with primary Sjögren's syndrome (pSS). Seventy-two patients diagnosed with pSS were included in the study. The patients with pSS were divided into two groups according to the presence/absence of neuropathic pain. The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire was recorded assess neuropathic pain. LUTS was evaluated using the International Prostate Symptom Score (IPSS), International Incontinence Consultation Questionnaire Short Form (ICIQ-SF) and Overactive Bladder Questionnaire (OAB-V8). The mean age of the patients was 52.4 ± 11.2 years. Neuropathic pain was recorded in 21 (29.2%) patients. Among the patients, the number of patients with mild symptoms was recorded as 41 (56.9%), moderate symptoms in 25 (34.7%), and severe symptoms in 6 (8.3%) according to IPSS. IPSS and IPSS voiding subscores were statistically significantly higher in patients with neuropathic pain than non-neuropathic pain group (p = 0.035; p = 0.001, respectively). Although ICIQ-SF, OAB-V8 and IPSS storage subscores were found to be higher in patients with neuropathic pain group, there was no statistically significant difference between the groups (p = 0.299; p = 0.283; p = 0.237, respectively). Neuropathic pain concomitant with PSS patients may negatively affect bladder voiding functions.